Gestational Diabetes MellitusNCT00550979
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
An observational study of Gestational Diabetes Mellitus, run by Brigham and Women's Hospital at 2 sites in United States.
Trial summary
The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers in women who have had a pregnancy complicated by diabetes as compared with women who have had a normal… Read more about this study
- Who is it for?
- Ages 18 to 40 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Gestational Diabetes Mellitus
- How many people
- 96 participants
- Where
- 2 sitesUnited States
- Study dates
- Sep 2007to Jan 2014
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Black and white women who have had uncomplicated pregnancies or pregnancies complicated by gestational diabetes in the past 5 years
Who may be able to join
- Healthy women of self-identified African descent (black) and European (white) ancestry
- 18-40 years of age
- Regular menstrual cycles
- 5 or less years postpartum
- Have either a normal or a GDM index pregnancy history
- Are in good health free of thyroid, cardiac, or renal disease
Who cannot join
- If you are pregnant
- If you are lactating
Trial locations and contacts
2 sites in 1 country.
United States2 sites, 2 recruiting
- Recruiting
Brigham and Women's Hospital, Massachusetts General Hospital
Boston, Massachusetts, 02115
Rhonda Bentley-Lewis, MD
Florence Brown, MD
- Recruiting
Brigham and Women's Hospital
Boston, Massachusetts, 02115
About this study
The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers in women who have had a pregnancy complicated by diabetes as compared with women who have had a normal pregnancy.
- Conditions
- Gestational Diabetes Mellitus
- Keywords
- gestational diabetes mellitus, cardiovascular disease risk, heart disease risk
- Medical subject headings
- Diabetes, Gestational
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Black women with history of pregnancy/ies complicated by gestational diabetes mellitus | |
| 2 | Black women with history of normal, uncomplicated pregnancy/ies | |
| 3 | White women with a history of pregnancy/ies complicated by gestational diabetes. | |
| 4 | White women with a history of normal, uncomplicated pregnancy/ies. |
What is being measured
The primary outcome is the main question the study is designed to answer.
endothelial function
Measured: same day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Oct 2007 (estimated)
- Study startSep 2007
- Primary completionOct 2013 (estimated)
- Study completionJan 2014 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gestational Diabetes MellitusStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 96 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Massachusetts General Hospital, Joslin Diabetes Center
- Responsible party
- Principal investigator, Rhonda Bentley-Lewis, MD, Brigham and Women's Hospital
- Investigators
- Rhonda Bentley-Lewis, MD, Principal investigator, Brigham and Women's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00550979
- Sponsor's protocol ID
- 2007P001406
- Status last verified
- Aug 2013
- First submitted
- 26 Oct 2007
- Last updated
- 29 Aug 2013
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Aug 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
- ClinicalTrials.gov ID
- NCT00550979
- Acronym / sponsor ID
- 2007P001406
- Conditions
- Gestational Diabetes Mellitus
- Keywords
- gestational diabetes mellitus, cardiovascular disease risk, heart disease risk
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 96 participants (estimated)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Collaborators
- Massachusetts General Hospital, Joslin Diabetes Center
- Study start
- Sep 2007
- Primary completion
- Oct 2013 (estimated)
- Study completion
- Jan 2014 (estimated)
- First posted
- 30 Oct 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers in women who have had a pregnancy complicated by diabetes as compared with women who have had a normal pregnancy.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| 1 | – | –Black women with history of pregnancy/ies complicated by gestational diabetes mellitus |
| 2 | – | –Black women with history of normal, uncomplicated pregnancy/ies |
| 3 | – | –White women with a history of pregnancy/ies complicated by gestational diabetes. |
| 4 | – | –White women with a history of normal, uncomplicated pregnancy/ies. |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Black and white women who have had uncomplicated pregnancies or pregnancies complicated by gestational diabetes in the past 5 years
Key inclusion criteria (6 listed)
- Healthy women of self-identified African descent (black) and European (white) ancestry
- 18-40 years of age
- Regular menstrual cycles
- 5 or less years postpartum
- Have either a normal or a GDM index pregnancy history
Key exclusion criteria (2 listed)
- If you are pregnant
- If you are lactating
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
endothelial function
Time frame: same day
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Aug 2013.
Related trials for Gestational Diabetes Mellitus
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Not yet recruitingObservational study
Ultrasound Assessment Of Gastric Volume In Pregnant Women Undergoing Elective Cesarean Section
Gestational Diabetes Mellitus (GDM), Obstetric Anesthesia
Active, not recruitingPhase 2
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
Weight Loss, Gestational Diabetes Mellitus in Pregnancy
Not yet recruiting
STRONG: SMART Trial
Gestational Diabetes Mellitus (GDM)
Not yet recruiting
A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia
Adverse Pregnancy Outcomes, Cardiovascular Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rhonda Bentley-Lewis, MD principal investigator
Brigham and Women's Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gestational Diabetes Mellitus, run by Brigham and Women's Hospital at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Research Assistant (617-724-3504, RBLResearchGroup@partners.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
endothelial function (time frame: same day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2013.